Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
David Rosa, CEO and President of NeuroOne Medical Technologies, disposed of 4,697 shares of common stock on December 31, 2024, to cover tax obligations.
Summary
- On December 31, 2024, David A. Rosa, CEO and President of NeuroOne Medical Technologies Corp, disposed of 4,697 shares of common stock.
- The transaction was executed at a price of $0.826 per share.
- Following the transaction, Mr. Rosa directly owns 1,137,311 shares of NeuroOne Medical Technologies Corp.
- The disposition of shares was related to covering tax obligations.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a transaction to cover tax obligations, which is a routine event.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. This allows investors to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the slight dilution of shares, but it is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of transaction: David Rosa disposed of shares. |
| 01/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.